ECM
DARE icon

ExodusPoint Capital Management’s Dare Bioscience DARE Stock Holding History

ExodusPoint Capital Management’s Portfolio DARE Stock Details DARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-6,055
Closed -$108K – 2033
2022
Q1 		$108K Buy
+6,055
New +$114K ﹤0.01% 1997
2021
Q2 		– Sell
-1,564
Closed -$32K – 2444
2021
Q1 		$32K Buy
+1,564
New +$38.2K ﹤0.01% 2050

Other funds holding DARE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SAM
Soviero Asset Management New York $200M AUM 134.59% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
FFS
Founders Financial Securities Towson, Maryland $1.77B AUM 17.63% 1-Year Est. Return
FFA
Founders Financial Alliance Raleigh, North Carolina $555M AUM 22.31% 1-Year Est. Return

ExodusPoint Capital Management's DARE Position: Q2 2022 in Review

ExodusPoint Capital Management sold out of Dare Bioscience (DARE) in Q2 2022, closing a stake of 6,055 shares — an estimated $108K sold.

ExodusPoint Capital Management first reported a position in DARE in Q1 2021 and held it in 2 quarters. The position peaked at $108K in Q1 2022. 36 funds tracked by Wall St. Rank hold DARE as of Q2 2022.

  • ExodusPoint Capital Management reported no remaining Dare Bioscience position as of Q2 2022 after selling out during the quarter.
  • ExodusPoint Capital Management sold 6,055 Dare Bioscience shares in Q2 2022, an estimated $108K.
  • ExodusPoint Capital Management first reported a position in Dare Bioscience in Q1 2021 and held it in 2 quarters.
  • ExodusPoint Capital Management's Dare Bioscience position peaked at $108K in Q1 2022.
  • 36 funds tracked by Wall St. Rank held Dare Bioscience as of Q2 2022.

Based on ExodusPoint Capital Management's 13F filing for Q2 2022, filed 22 Aug 2022.